Join a Clinical Trial
Whether you are eligible for a research study depends on many things. There are specific requirements to be in research studies. These requirements are different for each clinical trial.
Clinical Trial Details
Venetoclax in Combination with Azacitidine or Decitabine for Patients with Newly-diagnosed Acute Myeloid Leukemia (AML) and High-grade Myelodysplastic Syndrome (MDS) Who are Medically Unfit for Intensive Induction Therapy
Complete Title: Venetoclax in Combination with Azacitidine or Decitabine for Patients with Newly-diagnosed Acute Myeloid Leukemia (AML) and High-grade Myelodysplastic Syndrome (MDS) Who are Medically Unfit for Intensive Induction Therapy
Trial Phase: N/A
Investigator: Anna Halpern
Disclaimer: We update this information regularly. However, what you read today may not be completely up to date.
Contact Us
If you are seeking to schedule an appointment, we are here to help. You can either call us or fill out our online appointment request form.
N/A
Anna Halpern
RG1006293
Venetoclax in Combination with Azacitidine or Decitabine for Patients with Newly-diagnosed Acute Myeloid Leukemia (AML) and High-grade Myelodysplastic Syndrome (MDS) Who are Medically Unfit for Intensive Induction Therapy